Sonographic assessment offers several advantages in the diagnosis of Neural Tube Defects(NTDs). It is a safe and non-invasive procedure that poses minimal risks to both the mother andthe fetus. During the 1st trimester, sonographic assessment includes measurement of nuchaltranslucency (NT), which, when increased, indicates a higher risk of NTDs and chromosomalabnormalities. In the 2nd trimester, a detailed anatomical scan evaluates the neural tube, brain,spine, and associated structures. Objective: To screen sonographically for the prenatalst nd diagnosis of Neural Tube defects during 1 and 2 trimesters of pregnancy. Methods: Aprospective cohort study done in 9 months at Gilani Ultrasound Centre, Lahore, Pakistan byconsecutive sampling. Total 7552 samples were estimated. We included all pregnant femalesvisiting for regular antenatal checkup age between 18-45 years and Gestational age from weekth th 6 till 26 weeks with any parity and excluded females needing emergency intervention. Results:Out of 7552 patients 319(4.24%) of fetuses were seen with minor abnormalities (SonologicalMarkers) in 319(4.28%) of patients examined of which 89(28.07%). Mild microcephaly was seen innd 24(7.57%), of which 3 were seen in the 2 trimester and 21 were seen in the 3rd trimester. Manyother disorders were also observed in very low number of patients. Conclusion: Sonographicassessment is an essential tool in the prenatal screening and diagnosis of NTDs during the 1stand 2nd trimesters of pregnancy. Its widespread use and continuous improvement intechnology have signi??cantly contributed to the improved diagnosis and care of NTDs inprenatal settings.